293 results match your criteria: "Royal Brompton and Harefield hospital[Affiliation]"

Background: Atrial septal defects (ASDs) can be symptomatic in small children in cases of co-morbidities. Transcatheter closure remains controversial for large defects in small children.

Objective: To describe transcatheter closure of ASDs in children with device/weight ratio ≥1.

View Article and Find Full Text PDF

Coronary and structural interventions: novel evidence for decision making.

Eur Heart J

May 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Atrial fibrillation and arrhythmias: novel risk assessment, proper anticoagulation, and ablation.

Eur Heart J

April 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on comparing the Organ Care System (OCS) Lung device with traditional cold storage for preserving donor lungs during lung transplantation, specifically addressing the issue of severe primary graft dysfunction (PGD3).
  • The trial involved 370 patients, with 320 undergoing transplantation, and aimed to determine the effectiveness of the OCS in preventing PGD3 and ensuring 30-day survival.
  • Results indicated that the OCS showed a slightly higher rate of success in preventing PGD3 compared to cold storage, achieving non-inferiority but not quite reaching statistical superiority.
View Article and Find Full Text PDF

The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults.

View Article and Find Full Text PDF

Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial.

Am J Gastroenterol

July 2018

University of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. Cleveland Clinic, Cleveland, OH, USA. Downstate College of Medicine, State University of New York, New York, NY, USA. Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. Pfizer, New York, NY, USA. Pfizer Ltd, Tadworth, UK.

View Article and Find Full Text PDF

Novel insights in HFpEF, cardiomyopathies, and myocarditis.

Eur Heart J

March 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Epidemiology of cardiovascular disease: the new ESC Atlas and beyond.

Eur Heart J

February 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Frontiers in cardiac imaging: diagnostic and prognostic validity and safety.

Eur Heart J

January 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Introduction: Ventricular perforation during radiofrequency ablation of ventricular tachycardia is a recognized serious complication that carries high morbidity and mortality. Perforation is often associated with local intramyocardial injury due to excess heat induced by catheter, 'steam pop'. The complication usually requires emergency surgical repair.

View Article and Find Full Text PDF

Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine.

Circ Res

January 2018

From the Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain (F.F.-A., R.S.-R., A.M.C.); CIBERCV, ISCIII, Madrid, Spain (F.F.-A., R.S.-R., A.M.C., L.B., V.F.); Cardiovascular Research Center (ICCC), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (L.B.); Institute of Molecular Cardiology, Diabetes and Obesity Center, University of Louisville School of Medicine, KY (R.B.); LabEx TRANSPLANTEX, Paris, France (D.C.); HLA and Médecine Jean Dausset Laboratory Network, Hôpital Saint-Louis AP-HP, Université Paris Diderot, France (D.C.); Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (V.F.); Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY (V.F.); Department of Cardiovascular Sciences, KU Leuven, Belgium (S.J.); Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Denmark (J.K.); National Research Laboratory for Stem Cell Niche, Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea (H.-S.K.); Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Korea (H.-S.K.); Department of Cardiology, Royal Brompton and Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, England (T.F.L); University College of London, England (J.F.M.); Department of Cardiovascular Surgery Hôpital Européen Georges Pompidou, Paris, France (P.M.); Université Paris Descartes, Sorbonne Paris Cité, France (P.M.); Serviço de Cardiologia, Hospital Universitário de Santa Maria, CAML, Centro Cardiovascular da Universidade de Lisboa, Universidade de Lisboa, Portugal (F.J.P.); School of Medicine, University of Kansas, Lawrence (R.D.S.); Center for Clinical Trials, Cardiovascular Research Foundation, New York, NY (G.W.S.); Center for Clinical Trials, NewYork-Presbyterian Hospital, Columbia University Medical Center (G.W.S.); Center for Regenerative Medicine (A.T.), Department of Cardiovascular Diseases (A.T.), and Department of Molecular Pharmacology and Experimental Therapeutics (A.T.), Mayo Clinic, Rochester, NY; Department of Regenerative Medicine Research, Texas Heart Institute, Houston (J.T.W.); and Division of Cardiovascular Medicine, Department of Medicine, Stanford Cardiovascular Institute (J.C.W.) and Department of Radiology (J.C.W.), Stanford University School of Medicine, CA.

View Article and Find Full Text PDF

Dual antiplatelet therapy: how, how long, and in which patients?

Eur Heart J

January 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

ST-segment elevation myocardial infarction: the new ESC Guidelines.

Eur Heart J

January 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Exercise Hemodynamic and Functional Capacity After Mitral Valve Replacement in Patients With Ischemic Mitral Regurgitation: A Comparison of Mechanical Versus Biological Prostheses.

Circ Heart Fail

January 2018

>From the Cardiovascular Department, Ospedale Papa Giovanni XXIII, Bergamo, Italy (C.F., A.I., P.F., M.M., L.G., P.F., D.C., M.S.); Hypertrofic Cardiomyopathy Centre, Policlinico di Monza, Monza, Italy (P.F.); Québec Heart & Lung Institute, Department of Medicine, Laval University, Quebec City, QC, Canada (P.P.); Department of Cardiothoracic Surgery, Royal Brompton and Harefield Hospital, London, United Kingdom (J.R.P.); Bristol Royal Infirmary, University of Bristol, United Kingdom (M.C.); Surgical Skills Centre, Manchester Science Park, United Kingdom (C.A.); Division of Cardiovascular Diseases, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT), Palermo, Italy (D.B.); and CHU Limoges, Hôpital Dupuytren, Service Cardiologie, France (J.M.).

Background: In patients with ischemic mitral regurgitation requiring mitral valve replacement (MVR), the choice of the prosthesis type is crucial. The exercise hemodynamic and functional capacity performance in patients with contemporary prostheses have never been investigated. To compare exercise hemodynamic and functional capacity between biological (MVRb) and mechanical (MVRm) prostheses.

View Article and Find Full Text PDF

Heart failure subgroups: HFrEF, HFmrEF, and HFpEF with or without mitral regurgitation.

Eur Heart J

January 2018

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Biologic agents for severe asthma patients: clinical perspectives and implications.

Intern Emerg Med

March 2018

Department of Clinical and Experimental Medicine, A.O.U. Policlinico - Vittorio Emanuele, Università degli Studi di Catania, Via S. Sofia, 78, 95123, Catania, Italy.

Asthma is a chronic inflammatory multifactorial disorder of the airways characterized by the involvement of immune cells and mediators in its onset and maintenance. Traditional therapeutic strategies have been unsatisfactory in controlling the underlying pathology, especially in the more severe states. Hence in the last couple of decades, new biological approaches targeting molecular mediators have been developed.

View Article and Find Full Text PDF

Managing aortic stenosis with TAVI or surgery: risk assessement and long-term outcome.

Eur Heart J

December 2017

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Frontiers of Prevention: Pollution, Infection, Cognitive Function and Frailty.

Eur Heart J

November 2017

Editorial Office, Zurich Heart House, 8032 Zurich, Center for Molecular Cardiology, Schlieren Campus, University of Zurich, Switzerland and Royal Brompton and Harefield Hospital Trust and Imperial College, London, SW3 6NP, UK.

View Article and Find Full Text PDF

Conventional cigarette smoking is known to result in significant COPD morbidity and mortality. Strategies to reduce and/or stop smoking in this highly vulnerable patient group are key public health priorities to reduce COPD morbidity and mortality. Unfortunately, smoking cessation efforts in patients with COPD are poor and there is a compelling need for more efficient approaches to cessation for patients with COPD.

View Article and Find Full Text PDF